Increased Cancer Risk Associated with Treatment for Diabetic Leg and Foot Ulcers
March 28th, 2008 • Related • Filed Under
The FDA is conducting a safety review based on study data suggesting there may be an increased risk of death from cancer in diabetic patients using Regranex (becaplermin) Gel, a skin product used to heal leg and foot ulcers. While the review is ongoing, the FDA recommends health care professionals discuss the potential risks and benefits of using Regranex with their patients.
Popularity: 66% [?]
Pingback by My Cancer Treatments » Blog Archive » Increased Cancer Risk Associated with Treatment for Diabetic Leg and… on 28 March 2008:
[...] Class Action Lawsuits | Lawsuits? Get your Class action lawsuit information here wrote an interesting post today onHere’s a quick excerpt [...]
Pingback by ulcers on 9 April 2008:
[...] someday save your life, it is being reported.http://www.foxnews.com/story/0,2933,347273,00.htmlIncreased Cancer Risk Associated with Treatment for DiabeticThe FDA is conducting a safety review based on study data suggesting there may be an increased risk [...]